Gene expression profiles in the fetal mouse brain after etoposide (VP-16) administration

Exp Anim. 2013;62(2):93-9. doi: 10.1538/expanim.62.93.

Abstract

The aim of this study was to analyze the response of gene expression caused by etoposide (VP-16) in the fetal mouse brain. Four miligrams/kilogram of VP-16 was intraperitoneally injected into pregnant mice on day 12 of gestation (GD 12). Gene expression profiling of the VP-16-treated fetal mouse brain by DNA microarray was performed. The expression changes of the target genes of p53 were also examined by real-time RT-PCR. VP-16 induced S-phase accumulation, G2/M arrest, and eventually apoptosis of neuroepithelial cells in the fetal brain. DNA microarray analysis revealed that 8 of cell cycle control- and apoptosis-related genes were upregulated and that 5 of DNA damage, repair, replication, and transcription genes were also upregulated in the fetal telencephalons at 4 h after VP-16 treatment (HAT). The results of real-time RT-PCR demonstrated that the expression of topoisomerase IIα was increased at 4 and 8 HAT. The expression of pro-apoptotic factors such as puma, noxa, bax, and cyclin G was also increased from 4 to 12 HAT. These results suggest that VP-16 induces DNA damage, DNA repair, cell cycle alternation, and apoptosis in the fetal mouse brain. In addition, VP-16-induced apoptosis is mediated through the mitochondrial pathway in a p53-related manner. The present study will provide a better understanding of the mechanisms of VP-16-induced fetal brain injury.

MeSH terms

  • Animals
  • Antigens, Neoplasm / metabolism
  • Antineoplastic Agents, Phytogenic / adverse effects*
  • Apoptosis / drug effects*
  • Apoptosis / genetics
  • Brain / cytology
  • Brain / embryology*
  • Brain / pathology*
  • Cell Cycle Checkpoints / drug effects
  • Cell Cycle Checkpoints / genetics
  • DNA Damage / drug effects
  • DNA Topoisomerases, Type II / metabolism
  • DNA-Binding Proteins / metabolism
  • Etoposide / administration & dosage
  • Etoposide / adverse effects*
  • Female
  • Gene Expression Regulation, Developmental / drug effects*
  • Genes, p53 / genetics*
  • Injections, Intraperitoneal
  • Mitochondria / genetics
  • Mitochondria / physiology
  • Neuroepithelial Cells / pathology
  • Pregnancy
  • Transcriptome / drug effects*
  • Up-Regulation / drug effects

Substances

  • Antigens, Neoplasm
  • Antineoplastic Agents, Phytogenic
  • DNA-Binding Proteins
  • Etoposide
  • DNA Topoisomerases, Type II